DLinDMA is a benchmark cationic lipid used in stable nucleic acid lipid particles (SNALPs) for research. It is widely employed in vitro and in vivo for the delivery of RNAi therapeutics and mRNA vaccines, facilitating gene silencing and protein expression studies.
